Abiraterone: Hint of considerable added benefit for patients with metastatic prostate cancer
Tuesday, July 2, 2013 - 14:30
in Health & Medicine
Abiraterone can prolong life and delay the occurrence of severe pain in patients with metastatic prostate cancer that is not responsive to hormone blockade, in whom chemotherapy is not yet indicated. However, greater harm in the form of side effects cannot be excluded with certainty, experts say.